HealthQuill Obesity
Eli Lilly’s weight-loss injection Zepbound, taken along as a supplement with diet and exercise, got the USFDA and UK regulator’s nod after clinical trials proved adults lost 48 pounds on average during treatment.
Drugs Health Pharma

7-fold increase in use of GLP-1 weight loss drugs among teens, young adults

Research finds a sharp increase in use of weightloss drugs such as Ozempic and Wegovy among teens and young adults

Read More
Novo Nordisk, Europe’s most valuable company, has raised its 2024 revenue outlook on the back of its popular weight-loss drug Wegovy, as it announced its January to March operating profit rose 27% to Danish kroner 31.8 billion.
Drugs Health Pharma

Novo Nordisk raises sales forecast on strong demand for anti-obesity drug

HQ Team May 2, 2024: Novo Nordisk, Europe’s most valuable company, has raised its 2024 revenue outlook on the back of its popular.

Read More
Experiencing a way to eat out of a stressful situation —even in the absence of appetite — is a very common occurrence and it is an underrated reason for morbid obesity. 
Drugs Health Opinion Pharma

Opinion: Overeating under stress can alter your neurochemistry

By Aparna S April 22, 2024: Stress is an underrated cause of obesity — the gateway for many lifestyle diseases in today’s sedentary.

Read More
US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side effects.
Drugs Health Pharma

Viking Therapeutics’ weight-loss drug shows ‘positive’ results in early trials

US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side.

Read More
Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company announced.
Drugs Health Pharma

Novo Nordisk unveils new drug to fight obesity, says 13% effective

HQ Team March 11, 2024: Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company.

Read More
Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction, a study by the University of British Columbia found.
Drugs Health Medical

Study finds unexpected link between weight loss and cancer risk

HQ Team March 4, 2024: Obesity is widely recognized as a risk factor for cancer, and a recent study sheds light on an.

Read More
More than one billion people worldwide are living with obesity and the disease has quadrupled among children and adolescents between five and 19 years of age, according to the World Health Organization.
Drugs Health Pharma

One billion people globally are suffering from obesity, says  WHO

HQ Team March 1, 2024: More than one billion people worldwide are living with obesity and the disease has quadrupled among children and.

Read More
Food crisis
Drugs Health Medical

Unveiling the impact of fasting diets on eating behaviors, sleep, and mood

HQ Team January 29, 2024: Fasting diets (FDs) have gained popularity for their impact on health, disease, and weight control. Despite the vast.

Read More
The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the drug’s identity, quality or safety.
Drugs Health Pharma

FDA starts crackdown against fake Ozempic weight-loss drug 

HQ Team December 22, 2023: The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the.

Read More
— at a time when President Emmanuel Macron is taking steps to stem the country’s industrial decline.
Drugs Health Pharma

Novo Nordisk invests $2.3b in France for diabetes, obesity drugs

HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..

Read More